UBR7 and breast neoplasm: This analysis revealed reduced UBR7 expression in triple-negative and basal-like breast tumors (Fig. 3a), which was confirmed in an independent cohort of breast cancer tissue microarrays (TMAs) containing 371 breast tumors using a UBR7-specific antibody (Supplementary Fig. 4a and Supplementary Data 2).